Open house Arzneimittelrabattverträge Fingolimod in der Wirkstärke 0,25 mg, ATC L04AE01

AOK Bayern - Die Gesundheitskasse·München, Germany·Deadline Feb 03, 2028 · 524 days left·Open·Supplies·Framework

Structured notice only

Original notice title

Germany – Pharmaceutical products – Open house Arzneimittelrabattverträge Fingolimod in der Wirkstärke 0,25 mg, ATC L04AE01

50/100

Opportunity Score

PromisingLow complexity

SuppliesFrameworkOpen

Why this score?

Opportunity

50 / 100

Complexity

30 / 100

Risk factors

No estimated value or volume is provided. The actual revenue potential is unknown.

Open-house agreements can be automatically superseded by other rebate contracts won in competitive procedures for the s...

Deep Portfolio Analysis

Deep Company Fit Analysis

Uses:

Description
Industries & Services
Capabilities
Market & Experience
Certifications

Overview

Strong opportunity

Key Facts

Framework procurement
Supplies contract
1 lot
Duration until Mar 2028
Non-exclusive rebate agreements for Fingolimod 0.25 mg (ATC L04AE01)
Supply of pharmaceutical product containing active substance Fingolimod 0.25 mg

Show full summary

This is an open-house model for non-exclusive rebate agreements (Rabattverträge) for the active substance Fingolimod 0.25 mg (ATC L04AE01) with AOK Bayern. All interested pharmaceutical companies meeting the eligibility criteria can enter into identical, non-negotiable agreements. Contracts run from the earliest start date of 01.04.2026 to 31.03.2028. Joining is possible anytime until 03.02.2028.

Risks

No estimated value or volume is provided. The actual revenue potential is unknown.

Open-house agreements can be automatically superseded by other rebate contracts won in competitive procedures for the s...

Analysis may be incomplete

Only part of the procurement documentation was analyzed. Additional eligibility requirements, certificates, or submission documents may exist in the remaining tender documentation.

Key Requirements

Eligibility

Only pharmaceutical companies are eligible as potential contract partners.

Administrative

Submit signed contract, signed annex 'Festlegung der vertragsgegenständlichen Arzneimittel', and signed self-declaration of reliability.
Submission options: paper (two originals) or electronic with qualified electronic signature via DTVP communication area.

Requirements may be incomplete.

Buyer

Name

AOK Bayern - Die Gesundheitskasse

Location

München, DEU

[email protected]

Website

www.aok.de

Buyer profile

Open profile

Identifier

DE811695320

Activity

Health

Lots (1)

LOT-0001

Open house Arzneimittelrabattverträge Fingolimod in der Wirkstärke 0,25 mg, ATC L04AE01

Open house for non-exclusive rebate agreements on Fingolimod 0.25 mg. Any eligible pharmaceutical company can join. Contracts are identical and non-negotiable. Duration from 01.04.2026 to 31.03.2028.

SuppliesFrameworkEU fundedElectronic submission

Location

DE212, Germany

Duration

Mar 2026 - Mar 2028

Procurement Details

Publication date: 15 Feb 2026
Languages: German

Reference metadata

Legal basis: 32014L0024

Reference IDs

Tender ID: 106909-2026

Documents (2)

Procurement document 1 Submission portal 1

Similar tenders

Bulgaria – Pharmaceutical products – Динамична система за покупки за доставка на лекарствени продукти за Медицински институт на МВР

Jul 9

Germany – Pharmaceutical products – Abschluss nicht exkl. Arzneimittel-Rabattvereinb. nach § 130a Abs. 8 SGB V im Wege eines Open-House-Modells über Arzneimittel mit dem Handelsnamen Oralair(R) (ATC-Code nach WHO: V01AA02)

Aug 31

Germany – Pharmaceutical products – Abschluss nicht exkl. Arzneimittel-Rabattvereinb. nach § 130a Abs. 8 SGB V im Wege eines Open-House-Modells zum Wirkstoff Ipratropiumbromid (ATC-Code nach WHO: R03BB01)

Sep 30

Denmark – Pharmaceutical products – Amgros 2027 1.1170.a

Sep 3